Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict ...
Corporation (NASDAQ: CTSH) has announced the expansion of its partnership with biopharmaceutical company Gilead Sciences (NASDAQ: NASDAQ:GILD), aiming to enhance Gilead's customer service, employee ...
BOSTON - Elicio Therapeutics , Inc. (NASDAQ:ELTX), a clinical-stage biotech company focusing on cancer immunotherapies, has announced a registered direct offering priced at-the-market under Nasdaq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback